Literature DB >> 24001579

GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.

Maria Negahdar1, Ingvild Aukrust2, Janne Molnes3, Marie H Solheim4, Bente B Johansson5, Jørn V Sagen6, Knut Dahl-Jørgensen7, Rohit N Kulkarni8, Oddmund Søvik9, Torgeir Flatmark10, Pål R Njølstad11, Lise Bjørkhaug4.   

Abstract

GCK-MODY, dominantly inherited mild hyperglycemia, is associated with more than 600 mutations in the glucokinase gene. Different molecular mechanisms have been shown to explain GCK-MODY. Here, we report a Pakistani family harboring the glucokinase mutation c.823C>T (p.R275C). The recombinant and in cellulo expressed mutant pancreatic enzyme revealed slightly increased enzyme activity (kcat) and normal affinity for α-D-glucose, and resistance to limited proteolysis by trypsin comparable with wild-type. When stably expressed in HEK293 cells and MIN6 β-cells (at different levels), the mutant protein appeared misfolded and unstable with a propensity to form dimers and aggregates. Its degradation rate was increased, involving the lysosomal and proteasomal quality control systems. On mutation, a hydrogen bond between the R275 side-chain and the carbonyl oxygen of D267 is broken, destabilizing the F260-L271 loop structure and the protein. This promotes the formation of dimers/aggregates and suggests that an increased cellular degradation is the molecular mechanism by which R275C causes GCK-MODY.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aggregation; BCA; Catalytic activity; Cellular protein degradation; DMEM; GCK; GCK-MODY diabetes; GKRP; Glc; HEK; IFG; MIN; MODY; PDB; PFK-2/FBPase; PNS; Protein misfolding; RRL; Self-association; bicinchoninic acid; bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; dulbecco’s modified eagles medium; glucokinase gene; glucokinase regulatory protein; hGK; human embryonic kidney; human glucokinase; impaired fasting glucose; maturity-onset diabetes of the young; mouse insulinoma; post nuclear supernatant; protein data bank; rabbit reticulocyte lysate; α-D-glucose

Mesh:

Substances:

Year:  2013        PMID: 24001579     DOI: 10.1016/j.mce.2013.08.020

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  Lack of glibenclamide response in a case of permanent neonatal diabetes caused by incomplete inactivation of glucokinase.

Authors:  Josep Oriola; Francisca Moreno; Angel Gutiérrez-Nogués; Sara León; Carmen-María García-Herrero; Olivier Vincent; María-Angeles Navas
Journal:  JIMD Rep       Date:  2015-02-10

2.  GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.

Authors:  David Carmody; Rochelle N Naylor; Charles D Bell; Shivani Berry; Jazzmyne T Montgomery; Elizabeth C Tadie; Jessica L Hwang; Siri Atma W Greeley; Louis H Philipson
Journal:  Acta Diabetol       Date:  2016-04-22       Impact factor: 4.280

Review 3.  The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY).

Authors:  Ken Munene Nkonge; Dennis Karani Nkonge; Teresa Njeri Nkonge
Journal:  Clin Diabetes Endocrinol       Date:  2020-11-04

4.  Preliminary screening of mutations in the glucokinase gene of Chinese patients with gestational diabetes.

Authors:  Zhixin Wang; Fan Ping; Qian Zhang; Jia Zheng; Huabing Zhang; Miao Yu; Wenhui Li; Xinhua Xiao
Journal:  J Diabetes Investig       Date:  2017-05-24       Impact factor: 4.232

5.  Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia.

Authors:  Zhixin Wang; Chengming Diao; Yijing Liu; Mingmin Li; Jia Zheng; Qian Zhang; Miao Yu; Huabing Zhang; Fan Ping; Ming Li; Xinhua Xiao
Journal:  J Diabetes Investig       Date:  2019-02-01       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.